Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

• Status: Terminated
• Trial end date: 2009-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Washington University School of Medicine
• Collaborator: Society of Pediatric Urology
• Treatments: Midazolam

Criteria

Inclusion Criteria:

• Age 2-6 years

• Toilet trained

• English speaking

• Already scheduled for VCUG

Exclusion Criteria:

• Allergic to midazolam

• Active UTI

• Known urethral stricture

• Known urethral reconstruction

• Has history of abnormal sensation in pelvic area

• Has history of sexual abuse

• Has severe developmental delay

• Has diagnosis of anxiety disorders